Pharmacology & ToxicologyActa Pharmaceutica Sinica BPeer-reviewed
Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy
Hong-Toan Lai, Daniela Dias‐Pedroso, Maria Eugénia Marques Da Costa…·Catherine Brenner
This paper identifies M30-E05, an engineered flavonoid that disrupts the AIF/CHCHD4 mitochondrial complex, reducing cancer cell viability and tumor growth in xenograft models.
1 citation